Development of a Series of Aryl Pyrimidine Kynurenine Monooxygenase Inhibitors as Potential Therapeutic Agents for the Treatment of Huntington’s Disease
Toledo-Sherman, Leticia M, Prime, Michael E, Mrzljak, Ladislav, Beconi, Maria G, Beresford, Alan, Brookfield, Frederick A, Brown, Christopher J, Cardaun, Isabell, Courtney, Stephen M, Dijkman, Ulrike, Hamelin-Flegg, Estelle, Johnson, Peter D, Kempf, Valerie, Lyons, Kathy, Matthews, Kimberly, Mitchell, William L, O’Connell, Catherine, Pena, Paula, Powell, Kendall, Rassoulpour, Arash, Reed, Laura, Reindl, Wolfgang, Selvaratnam, Suganathan, Friley, Weslyn Ward, Weddell, Derek A, Went, Naomi E, Wheelan, Patricia, Winkler, Christin, Winkler, Dirk, Wityak, John, Yarnold, Christopher J, Yates, Dawn, Munoz-Sanjuan, Ignacio, Dominguez, Celia
Published in Journal of medicinal chemistry (12.02.2015)
Published in Journal of medicinal chemistry (12.02.2015)
Get full text
Journal Article